Skip to main content

. 1957 Aug 10;2(5040):323–325. doi: 10.1136/bmj.2.5040.323

Clinical Experience with Tolbutamide

G Walker, J D H Slater, E K Westlake, J D N Nabarro

PMCID: PMC1961998 PMID: 13446468

323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ACKERMAN I. P., CONN J. W., FAJANS S. S., GITTLER R. D., HENNES A. R., JOHNSON R. D., LOUIS L. H., SELTZER H. S., WAJCHENBERG B. L. Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects. Metabolism. 1956 Nov;5(6 Pt 2):820–839. [PubMed] [Google Scholar]
FRANKE H., FUCHS J. Ein neues antidiabetisches Prinzip; Ergebnisse klinischer Untersuchungen. Dtsch Med Wochenschr. 1955 Oct 7;80(40):1449–1452. doi: 10.1055/s-0028-1116221. [DOI] [PubMed] [Google Scholar]
KEMSLEY W. F. F. Body weight at different ages and heights. Ann Eugen. 1952 May;16(4):316–334. doi: 10.1111/j.1469-1809.1951.tb02484.x. [DOI] [PubMed] [Google Scholar]
WALKER G., LEESE W. L., NABARRO J. D. Hypoglycaemic sulphonamides in treatment of diabetes. Br Med J. 1956 Aug 25;2(4990):451–452. doi: 10.1136/bmj.2.4990.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
WRENSHALL G. A., BEST C. H. Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison. Can Med Assoc J. 1956 Jun 15;74(12):968–972. [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES